Effects of the ResQPod® on Maximum Concentration and Time to Maximum Concentration of Epinephrine in a Porcine Cardiac Arrest Model

Effects of the ResQPod® on Maximum Concentration and Time to Maximum Concentration of Epinephrine in a Porcine Cardiac Arrest Model

Cardiac arrest remains one of the leading causes of mortality with more than 900 occurrences daily in the United States alone claiming an estimated 325,000 lives each year, 1,000 people a day or one person every two minutes. The ResQPod®, an impedance threshold device (ITD), was developed to augment cardiac output during cardiopulmonary resuscitation (CPR). The American Heart Association (AHA) Guidelines 2005 for CPR and Emergency Cardiac Care gave the ResQPod® a Class IIa recommendation. The Class IIa recommendation means the intervention has very good evidence to support its use. Conversely, the 2010 AHA Guidelines state that it was not possible to determine the relative contribution of an ITD to the improved outcome. The use of an ITD may be considered by trained personnel as a CPR adjunct in adult cardiac arrest